Cancer gene theraphy

Surgical Oncology Clinics of North America

Volumn 7, Issue 3, 1998, Pages 421-469

  Cusack, J C ^a   Tanabe, K K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER RESEARCH; CANCER THERAPY; CLINICAL RESEARCH; EXPRESSION VECTOR; GENE THERAPY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; REVIEW; ANIMAL; CLINICAL TRIAL; GENE VECTOR; NEOPLASM;

ANIMALS; CLINICAL TRIALS; GENE THERAPY; GENETIC VECTORS; HUMANS; NEOPLASMS;

EID: 0031596384     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30255-2     Document Type: Review

References (173)

1. Aaltonen L.A. Peltomaki P. Leach F.S. Clues to the pathogenesis of familial colorectal cancer Science 260 1993 812
2. Aiello L. Guilfoyle R. Huebner K. Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293 Virology 94 1979 460
3. Anderson W.F. Blaese R.M. Culver K. The ADA human gene therapy clinical clinical protocol Hum Gene Ther 1 1990 331
4. Badie B. Drazan K.E. Kramer M.H. Adenovirus-mediated p53 gene delivery inhibits 91 glioma growth in rats Neurol Res 17 1995 209
5. Ballay A. Levrero M. Buendia M-A In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumen from recombinant human adenoviruses EMBO J 4 1985 3861
6. Barringer J.R. Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions N Engl J Med 288 1973 648
7. Bartholomew R.M. Esser A.F. Muller-Eberhard H.J. Lysis of oncornaviruses by human serum: Isolation of the viral complement (Cl) receptor and identification as pl5E J Exp Med 147 1978 844
8. Berns K.I. Cheung A. Ostrove J. Adeno-associated virus latent infection Mahy B.W.J. Minson A.C. Darby G.K. Virus Persistence 1982 Cambridge University Press Cambridge 249
9. Bischoff J.R. Kirn D.H. Williams A. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells Science 274 1996 373
10. Bishop J.M. Molecular themes in oncogenesis Cell 64 1991 235
11. Blaese R.M. Development of gene therapy for immunodeficiency: Adenosine deaminase deficiency Pediatr Res 33 1993 549 (suppl)
12. Blaese R.M. Culver K.W. Gene therapy for primary immunodeficiency disease Immunodeficiency Reviews 3 1992 329
13. Borelli E. Heyman R. Hsi M. Targeting of an inducible toxic phenotype in animal cells Proc Natl Acad Sci U S A 85 1988 7572
14. Boviatsis E.J. Chase M. Wei M.X. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors Hum Gene Ther 5 1994 183
15. Boviatsis E.J. Park J.S. Sena-Esteves M. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus that retains an intact thymidine kinase gene Cancer Res 54 1994 5745
16. Boviatsis E.J. Scharf J.M. Chase M. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase Gene Ther 1 1994 323
17. Breakefield X.O. Kramm C.M. Chiocca E.A. Herpes simlex virus vectors for tumor therapy Sobol R.E. Scanlon K.J. The Internet Book of Gene Therapy 1995 CT, Appleton and Lange Stamford 41
18. Bridgewater J.A. Knox R.J. Pitts J.D. The bystander effect of the nitroreductase/CB 1954 enzyme/prodrug system is due to a cell-permeable metabolite Hum Gene Ther 8 1997 709
19. Brody S.L. Jaffe H.A. Han S.K. Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors Hum Gene Ther 5 1994 437
20. Bunnell B.A. Askari F.K. Wilson J.M. Targeted delivery of antisense oligonucleotides by molecular conjugates Somat Cell Mol Genet 18 1992 559
21. Calabretta B. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: Biological and therapeutic implications Cancer Res 51 1991 4505
22. Carroll N.M. Chiocca E.A. Takahashi K. Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus Ann Surg 224 1996 323
23. Caruso M. Panis Y. Gagandeep S. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene Proc Natl Acad Sci U S A 90 1993 7024
24. Chen S-H Shine H.D. Goodman J.C. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo Proc Natl Acad Sci US A 91 1994 3054
25. dayman G.L. El-Naggar A.K. Roth J.A. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma Cancer Res 55 1995 1
26. dayman G.L. Liu T.J. Overholt S.M. Gene therapy for head and neck cancer: Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21 Arch Otolaryngol Head Neck Surg 122 1996 489
27. Cole D.J. Wilson M.C. Baron P.L. Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge Hum Gene Ther 7 1996 1381
28. Corey L. Spear P.G. Infections with herpes simplex viruses N Engl J Med 314 1986 749
29. Cosset F.L. Russell S.J. Targeting retrovirus entry Gene Ther 3 1996 946
30. Cotten M. Wagner E. Zatloukal K. High-efficiency receptor mediated delivery of small and large (48 kilbase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles Proc Natl Acad Sci U S A 89 1992 6094
31. Cristiano R. Roth J. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor Cancer Gene Ther 3 1996 4
32. Cristiano R.J. Smith L.C. Kay M.A. Hepatic gene therapy: Efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex Proc Natl Acad Sci U S A 90 1993 11548
33. Crystal R.G. Transfer of genes to humans: Early lessons and obstacles to success Science 270 1995 404
34. Culver K.W. Ram Z. Wallbridge S. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 256 1992 1550
35. Curiel D.T. Wagner E. Cotten M. High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes Hum Gene Ther 3 1992 147
36. Cusack J.C. Spitz F.R. Nguyen D. High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus Cancer Gene Ther 3 1996 245
37. Dai Y. Roman M. Naviaux R. Gene therapy via primary myoblasts: Long-term expression of Factor IX protein following transplantation in vivo Proc Natl Acad Sci USA 89 1992 10392
38. Davidson B.L. Allen E.D. Kozarsky K.F. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector Nat Genet 3 1993 219
39. Deatly A.M. Spivack J.G. Lavi E. RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice Proc Natl Acad Sci USA 84 1987 3204
40. DiMaio J.M. Clary B.M. Via D.F. Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo Surgery 116 1994 205
41. Domin B.A. Mahony W.B. Zimmerman T.P. Transport of 5-fluorouracil and uracil into human erythrocytes Biochem Pharmacol 46 1993 503
42. Donahue R.E. Kessler S.W. Bodine D. Helper virus induced T cell lymphoma in nonhuman primates after retroviral-mediated gene transfer J Exp Med 176 1992 1125
43. Dranoff G. Jaffee E. Lazenby A. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colon-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci U S A 90 1993 3539
44. Dzierzak E.A. Papayannopoulou T. Mulligan R.C. Lineage-specific expression of a human B-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells Nature 331 1988 35
45. Elshami A A Kucharaczuk J.C. Sterman D.H. The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene Ann Surg 222 1995 298
46. Elshami A A Saavedra A. Zhang H. Gap junctions play a role in the bystander effect of the herpes simplex virus thymidine kinase ganciclovir system in vitro Gene Ther 3 1996 85
47. Englehardt J.F. Litzky L. Wilson J.M. Prolonged transgene in cotton rat lung with recombinant adenoviruses defective in E2a Hum Gene Ther 5 1994 1217
48. Englehardt J.F. Ye X. Doranz B. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver Proc Natl Acad Sci U S A 91 1994 6196
49. Episkopou V. Murphy A.J.M. Efstratiadis A. Cell-specified expression of a selectable hybrid gene Proc Natl Acad Sci U S A 81 1984 4657
50. Ezzeddine Z.D. Martuza R.L. Platika D. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene The New Biologist 3 1991 608
51. Fearon E.R. Molecular genetics of colorectal cancer Ann N Y Acad Sci 768 1995 101
52. Fearon E.R. Pardoll D.M. Itaya T. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response Cell 60 1990 397
53. Fearon E.R. Vogelstein B. A genetic model for colorectal tumorigenesis Cell 61 1990 759
54. Feng M. Cabrera G. Deshane J. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme Cancer Res 55 1995 2024
55. Fick J. Barker F.G. Dazin P. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro Proc Natl Acad Sci U S A 92 1995 11071
56. Flotte T.R. Afione S.A. Conrad C. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc Natl Acad Sci U S A 90 1993 10613
57. Frank K.B. Chiou J. Cheng Y. Interaction of herpes simplex virus-induced DNA polymerase with 9-(l,3-dihydroxy-2-propoxymethyl) guanine triphosphate J Biol Chem 259 1984 1566
58. Freeman S.M. Abboud C.N. Whartenby K.A. The “bystander effect”: Tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 53 1993 5274
59. Fueyo J. Gomez-Manzano C. Yung W.K. Adenovirus-mediated pl6/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells Oncogene 12 1996 103
60. Fujiwara T. Grimm E.A. Mukhopadhyay T. Induction of chemosensitivity in human lung cancer cells in vivo by an adenoviral-mediated transfer of the wild-type p53 gene Cancer Res 54 1994 2287
61. Gansbacher B. Bannerji R. Daniels B. Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity Cancer Res 50 1990 7820
62. Gansbacher B. Zier K. Daniels B. Interleukin 2 gene transfer abrogates tumori-genicity and induces protective immunity J Exp Med 172 1990 1217
63. Gao L. Wagner E. Cotten M. Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes Hum Gene Ther 4 1993 17
64. Geller A.I. Breakefield X.O. A defective HSV-1 vector expresses E. coli beta-galactosidase in cultured rat peripheral neurons Science. 241 1988 1667
65. Georges R.N. Mukhopadhyay T. Zhang Y. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct Cancer Res 53 1993 1743
66. Ghosh-Choudhury G. Haj-Ahmad Y. Brinkley P. Human adenovirus cloning vectors based on infectious bacterial plasmids Gene 50 1986 161
67. Goldstein D.J. Weller S.K. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for vims growth and DNA synthesis: Isolation and characterization of an ICP6 lacZ insertion mutant J Virol 62 1988 196
68. Goyette M.C. Cho K. Fasching C.L. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer Mol Cell Biol 12 1992 1387
69. Gutierrez A.A. Lemoine N.R. Sikora K. Gene therapy for cancer Lancet 339 1992 715
70. Halbert C.L. Alexander I.E. Wolgamot G.M. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells J Virol 69 1995 1473
71. Harris J.D. Gutierrez A.A. Hurst H.C. Gene therapy for cancer using tumor-specific prodrug activation Gene Ther 1 1994 170
72. Heise C. Sampson-Johannes A. Williams A. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents Nature Medicine 3 1997 639
73. Hermann F. Cancer gene therapy: Principles, problems, and perspectives Journal of Molecular Medicine 73 1995 157
74. Hirschowitz E.A. Ohwada A. Pascal W.R. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine Hum Gene Ther 6 1995 1055
75. Hodge J.W. Abrams S. Schlom J. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimualtory molecules Cancer Res 54 1994 5552
76. Hodgson C.P. The vector void in gene therapy: Can viral vectors and transfection be combined to permit safe, efficacious, and targeted gene therapy? BioTechnology 13 1995 222
77. Horwitz M. Adenoviridae and their replication Fields B.N. Knipe D.M. Virology ed 2 1990 Raven New York 1679
78. Huber B.E. Austin E.A. Good S.S. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase Cancer Res 53 1993 4619
79. Huber B.E. Austin E.A. Richards C.A. Metabolism of 5-fluorocytosine to 5-fluoro-uracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase Proc Natl Acad Sci U S A 91 1994 8302
80. Huber B.E. Richards C.A. Krenitsky T.A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy Proc Natl Acad Sci U S A 88 1991 8039
81. Huber B.E. Richards C.E. Austin E.A. Virus-directed enzyme/prodrug therapy (VDEPT) selectively engineering drug sensitivity into tumors Annals of New York Academy of Sciences 716 1994 104 114
82. Hunter T. Cooperation between oncogenes Cell 64 1991 249
83. Ishii-Morita H. Agbaria R. Mullen C.A. Mechanism of “bystander effect” killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment Gene Therapy 4 1997 244
84. Jaffe H.A. Danel C. Longenecker G. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver Nat Genet l 5 1992 372 378
85. Jin X. Nguyen D. Zhang W.W. Cell cycle arrest and inhibition of tumor cell proliferation by the pl6INK4 gene mediated by an adenovirus vector Cancer Res 55 1995 3250
86. Johnson P.A. Miyanohara A. Levine F. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1 J Virol 66 1992 2952
87. Kantor J. Irvine K. Abrams S. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine J Natl Cancer Inst 1992
88. Kao G.Y. Change L.J. Allen T.M. Use of cationic liposomes in enhanced DNA delivery to cancer cells Cancer Gene Ther 3 1996 250
89. Karasuyama H. Tohyama N. Tada T. Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene J Exp Med 169 1989 13
90. Kashani-Sabet M. Funato T. Florenes V.A. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme Cancer Res 54 1994 900
91. Kessler P.D. Podsakoff G.M. Chen X. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein Proc Natl Acad Sci U S A 93 1996 14082
92. Kim C.J. Prevette T. Cormier J. Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro } Immunother 20 1997 276
93. Kitamura T. Miyajima A. Functional reconstitution of the human interleukin-3 receptor Blood 80 1992 84
94. Krasnykh V.N. Mikheeva G.V. Douglas J.T. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism J Virol 70 1996 6839
95. Lee C-H Liu M. Sie K-L Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-a and topoisomerase Ila in prostate cancer Anticancer Res 16 1996 1805
96. Li Q. Kay M.A. Finegold M. Assessment of recombinant adenoviral vectors for hepatic gene therapy Hum Gene Ther 4 1993 403
97. Lillycrop K.A. Estridge J.K. Latchman D.S. The octamer binding protein Oct-2 inhibits transactivation of the herpes simplex virus immediate-early genes by the virion protein Vmw65 Virology 196 1993 888
98. Lowe S.W. Ruley H.E. Jacks T. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 74 1993 957
99. Ma L. Calvo F. Recent status of the antisense oligonucleotide approaches in oncology Fundam Clin Pharmacol 10 1996 97
100. Mar E. Chiou J. Cheng Y. Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxy-eth-oxy-methyl) guanine and 9-(l,3-dihydroxy-2-propoxymethyl) guanine J Virol 53 1985 776
101. Marais R. Spooner R.A. Light Y. Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination Cancer Res 56 1996 4735
102. Marasco W.A. Intrabodies: Turning the humoral immune system outside in for intracellular immunization Gene Ther 4 1997 11
103. McGeoch D.J. Dalrymple M.A. Davison A.J. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1 J Gen Virol 69 1988 1531
104. Merrouche Y. Negrier S. Bain C. Clinical application of retroviral gene transfer in oncology: Results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin J Clin Oncol 13 1995 410
105. Mesnil M. Piccoli C. Tiraby G. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins Proc Natl Acad Sci USA 93 1996 1831
106. Miller A.D. Miller D.G. Garcia J.V. Use of retroviral vectors for gene transfer and expression Methods Enzymol 217 1993 581
107. Mittal S.K. McDermott M.R. Johnson D.C. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter Virus Res 28 1993 67
108. Moolten F.L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy Cancer Res 46 1986 5276
109. Moolten F.L. Wells J.M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors J Natl Cancer Inst 82 1990 297
110. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety Proc Natl Acad Sci. USA. 93 1996 11341
111. Moss B. Poxviridae and their replication Fields B.N. Knipe D.M. Virology ed 2 1990 Raven New York 207
112. Mukhopadhyay T. Tainsky M. Cavender A.C. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA Cancer Res 51 1991 1744
113. Mullen C.A. The use of suicide vectors for the gene therapy of cancer Pharmacol Ther 63 1994 199
114. Mullen C.A. Kilstrup M. Blaese R.M. Transfer of bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system Proc Natl Acad Sci U S A 89 1992 33
115. Nabel E.G. Gordon D. Yang Z.Y. Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization Hum Gene Ther 3 1992 649
116. Nabel E.G. Tang Z. Muller D. Safety and toxicity of catheter delivery to the pulmonary vasculature in a patient with metastatic melanoma Hum Gene Ther 5 1994 1089
117. Oldfield E.H. Ram Z. Culver K.W. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir Hum Gen Ther 4 1993 36
118. Osaki T. Tanio Y. Tachibana I. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene Cancer Res 54 1994 5258
119. Pang S. Taneja S. Kaboo R. Prostate tissue specificity of the promoter for prostate specific antigen (PSA). Potential approach for the development of target specific gene therapy Gene Therap 1994 Cold Spring Harbor Laboratory Cold Spring Harbor, NY
120. Paoletti E. Applications of pox virus vectors to vaccination: An update Proc Natl Acad Sci U S A 93 1996 11349
121. Peplinski G.R. Tsung K. Whitman E.D. Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta Ann Surg Oncol 2 1995 151
122. Plautz G. Nabel E.G. Nabel G.J. Selective elimination of recombinant genes in vivo with a suicide retroviral vector The New Biologist 3 1991 709
123. Porgador A. Gansbacher B. Bannerji R. Anti-metastatic vaccination of tumorbearing mice with IL-2-gene-inserted tumor cells Int J Cancer 53 1993 471
124. Qin H. Chatterjee S.K. Recombinant vaccinia expressing interleukin-2 for cancer gene therapy Cancer Gene Therapy 3 1996 163
125. Quantin B. Perricaudet L.D. Tajbakhsh S. Adenovirus as an expression vector in muscle cells in vivo Proc Natl Acad Sci U S A 89 1992 2581
126. Redfield R.R. Wright D.C. James W.D. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease N Engl J Med 316 1987 673
127. Richards C.A. Austin E.A. Huber B.E. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy Hum Gene Ther 6 1995 881
128. Richards C.A. Wolberg A.S. Huber B.E. The transcriptional control region of the human carcinoembryonic antigen gene: DNA sequence and homology studies DNA Seq 4 1993 185
129. Rogulski K.R. Kim J.H. Kim S.H. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity Hum Gene Ther 8 1997 73
130. Roizman B. Sears A.E. Herpes simplex viruses and their replication Fields B.N. Knipe D.M. Howley P.M. Fields Virology ed 3 1996 Lippincott-Raven Philadelphia 2231
131. Rosenberg S.A. Newer approaches to cancer treatment DeVita V.T.J. Heilman S. Rosenberg S.A. Cancer Principles and Practice of Oncology 1993 JB Lippin-cott Philadelphia 2598
132. Rosenberg S.A. Aebersold P. Cornetta K. Gene transfer into humans: Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction N Engl J Med 323 1990 570
133. Rosenberg S.A. Spiess P. Lafreniere R. A new approach to the adoptive immunotherapy of cancer Science 223 1986 1318
134. Rosenberg S.A. Yannelli J.R. Yang J.C. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2 J Natl Cancer Inst 86 1994 1159
135. Rosenfeld M.A. Siegfried W. Yoshimura K. Adenovirus-mediated transfer of a recombinant al-antitrypsin gene to the lung epithelium in vivo Science 252 1991 431
136. Rosenfeld M.A. Yoshimura K. Trapnell B.C. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium Cell 68 1992 143
137. Roth J.A. Cristiano R.J. Gene therapy for cancer: What have we done and where are we going? J Natl Cancer Inst 88 1997 21
138. Sakai M. Morinaga T. Urano Y. The human a-fetoprotein gene J Biol Chem 260 1985 5055
139. Salgaller M.L. Marincola F.M. Cormie R.J.N. Immunization against epitopes in the human melanoma antigen gplOO following patient immunization with synthetic peptides Cancer Res 56 1996 4749
140. Samulski R.J. Zhu X. Xiao X. Targeted integration of adeno-associated virus (AAV) into human chromosome 19 EMBO J 10 1991 3941
141. Scanlon K. Jiao L. Funato T. Ribozyme-mediated cleavages of c-fos mRNA reduce gene expression of DNA synthesis enzymes and metallothionein Proc Natl Acad Sci USA 88 1991 10591
142. Schnierle B.S. Groner B. Retroviral targeted delivery Gene Ther 3 1996 1069
143. Setoguchi Y. Jaffe H.A. Chu C-S Intraperitoneal in vivo genetherapy to deliver dl -antitrypsin to the systemic circulation Am J Respir Cell Mol Biol 10 1994 369
144. Sikora K. Pandha H. Gene therapy for prostate cancer Br J Urol 79 1997 64
145. Simons JW: Phase I/II study of autologous human GM-CSF gene transduced prostate cancer vaccines in patients with metastatic prostate carcinoma. NIH Protocol 9408-082
146. Smythe W.R. Hwang H.C. Elshami A.A. Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene Ann Surg 222 1995 78
147. Sobol R.E. Shawler D. Dorigo O. Immunogene therapy of cancer Sobol R.E. Scanlong K.J. The Internet Book of Gene Therapy 1995 CT, Appleton and Lange Stamford 175
148. Soiffer R. Lynch T. Mihm M. A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor Hum Gene Ther 8 1997 111
149. Somia N.V. Zoppé M. Verma I.M. Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery Proc Natl Acad Sci U S A 92 1995 7570
150. Spitz F.R. Nguyen D. Skibber J.M. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer Anticancer Res 16 1996 3415
151. Steiner I. Kennedy P.G.E. Molecular biology of herpes simplex virus type 1 latency in the nervous system Mol Neurobiol 7 1993 137
152. Stevens J.G. Wagner E.K. Devi-Rao G.B. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons Science 235 1987 1056
153. Stratford-Pericaudet L.D. Makeh I. Perricaudet M. Widespread long-term gene transfer to mouse skeletal muscles and heart J Clin Invest 90 1992 626
154. Stratford-Perricaudet L.D. Levrero M. Chasse J-F Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector Hum Gene Ther 1 1990 241
155. Su H. Chang J.C. Xu S.M. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene Hum Gene Ther 7 1996 463
156. Tahara H. Zeh HJ3. Storkus W.J. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo Cancer Res 54 1994 182
157. Takahashi T. Carbone D. Nau M.M. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions Cancer Res 52 1992 2340
158. Tanaka T. Fumihiko K. Okabe S. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro Cancer Res 56 1996 1341
159. The FDA: Draft Addendum to the PTC in Human Somatic Cell and Gene Therapy. FDA, 1996. FDA Document D0262.
160. Tong X-W Agoulnik I. Blankenburg K. Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy Anticancer Res 17 1997 811
161. Treisman J. Hwu P. Minamoto S. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen Blood 85 1995 139
162. van Beusechem V.W. Kukler A. Heidt P.J. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone marrow cells Proc Natl Acad Sci U S A 89 1992 7640
163. Vincent N. Ragot T. Gilgenkrantz H. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene Nat Genet 5 1993 130
164. Wagner E. Zenke M. Cotten M. Transferrin-polycation conjugates as carriers for DNA uptake into cells Proc Natl Acad Sci USA 87 1990 3410
165. Wallack M.K. Sivanandham M. Ditaranto K. Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine Ann Surg 226 1997 198
166. Wang J. Bucana C.D. Roth J.A. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53 Cancer Gene Therapy 2 1995 9
167. Watanabe Y. Kuribayashi K. Miyatake S. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma Cl300 cells results in reduced tumori-genicity by augmented anti-tumor immunity Proc Natl Acad Sci U S A 86 1989 9456
168. Wei R.M. Gibson M. Spear P.G. Construction and isolation of transmissible retrovirus containing the SRC gene of harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 2 J Virol 39 1981 935
169. Xu G.W. Sun Z.T. Forrester K. Tissue-specific growth suppression and chemosen-sitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene Hepatology 24 1996 1264
170. Xu H.J. Zhou Y. Scigne J. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein Cancer Res 56 1996 2245
171. Yang Y. Nunes F. Berencsi K. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy Proc Natl Acad Sci U S A 91 1994 4407
172. Zabner J. Peterson D.M. Puga A.P. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats Nat Genet 6 1994 75
173. Zhang Y. Mukhopadhyay T. Donehower L.A. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype Hum Gene Ther 4 1993 451